-
Infusion-to-Oral Drug Delivery Company Acquired
A company with a technology for converting drugs given by intravenous infusion into pills and capsules was acquired Grünenthal Group, a provider of pain medications.
-
Laser-Immunotherapy Now in Cancer Clinical Trial
A new type of cancer treatment that precisely attacks tumors with synthetic antibodies activated by laser beams is being tested in an early-stage clinical trial.
-
Fertility Device Company Gains $9.7M in Early Funds
A two year-old medical device enterprise making a fertility tracker for women is raising $9.7 million in its first venture finance round.
-
Antibody Leads to Sharp Triglyceride, Cholesterol Drop
An experimental synthetic antibody was shown in a clinical trial to markedly reduce triglycerides and the types of cholesterol that contribute to heart disease.
-
Long-Acting Opioid Abuse Therapy Shown Working in Trial
An experimental long-acting drug was shown at least as effective, and in some cases superior, to the current standard of care for opioid use disorder.
-
Electronic Pulses Shown to Induce Cancer Immune Response
A medical device company presented results of preclinical studies showing its drug-free electronic pulse technology encourages the immune system to kill and clear cancer cells.
-
Seedless Fruit Varieties Seen As Food Security Boost
A review of studies evaluating techniques for producing seedless fruit concludes these techniques can contribute to higher yields that help ensure the security of food supplies.
-
Small-Business Grants Awarded for Neurological Diseases
A biotechnology company spun-off last year in a pharmaceutical industry merger is receiving small business research grants to advance its technology treating neurological disorders.
-
Oxford, Evotec Partner on Drug Discovery
A collaboration between University of Oxford and a German drug discovery company aims to speed promising new treatments to the market, including support for start-up enterprises.
-
Liquid Biopsy Lab to Reside at Cancer Institute
A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California.